BE865921A - Analogues des alcaloides de l'ergot - Google Patents

Analogues des alcaloides de l'ergot

Info

Publication number
BE865921A
BE865921A BE186745A BE186745A BE865921A BE 865921 A BE865921 A BE 865921A BE 186745 A BE186745 A BE 186745A BE 186745 A BE186745 A BE 186745A BE 865921 A BE865921 A BE 865921A
Authority
BE
Belgium
Prior art keywords
analogues
ergot alkaloids
ergot
alkaloids
alkaloids analogues
Prior art date
Application number
BE186745A
Other languages
English (en)
Inventor
E Beacco
M-L Bianci
A Minghetti
C Spalla
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of BE865921A publication Critical patent/BE865921A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/183—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
BE186745A 1977-04-19 1978-04-12 Analogues des alcaloides de l'ergot BE865921A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16096/77A GB1584464A (en) 1977-04-19 1977-04-19 Ergot alkaloids

Publications (1)

Publication Number Publication Date
BE865921A true BE865921A (fr) 1978-07-31

Family

ID=10071128

Family Applications (1)

Application Number Title Priority Date Filing Date
BE186745A BE865921A (fr) 1977-04-19 1978-04-12 Analogues des alcaloides de l'ergot

Country Status (16)

Country Link
US (1) US4230854A (fr)
JP (1) JPS53132599A (fr)
AT (1) AT369783B (fr)
BE (1) BE865921A (fr)
CA (1) CA1113410A (fr)
CH (1) CH637658A5 (fr)
CS (1) CS212760B2 (fr)
DE (1) DE2816773A1 (fr)
DK (1) DK145701C (fr)
FR (1) FR2387989A1 (fr)
GB (1) GB1584464A (fr)
HU (1) HU175173B (fr)
IE (1) IE46797B1 (fr)
NL (1) NL7804174A (fr)
SE (1) SE7804362L (fr)
SU (1) SU735154A3 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH646166A5 (it) * 1980-09-30 1984-11-15 Linnea Sa Procedimento di sintesi parziale della vincamina e di alcaloidi indolici correlati.
US4390625A (en) 1981-02-06 1983-06-28 Richter Gedeon Vegyeszeti Gyar Rt Method for controlling the amount and distribution of alkaloids formed in a fermentation process
FR2499589B1 (fr) * 1981-02-06 1985-11-15 Richter Gedeon Vegyeszet Procede pour regler la quantite et les proportions des alcaloides qui se forment lors de la fermentation
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
HU190141B (en) * 1983-08-10 1986-08-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu New process for production of clavin-type rye-smut alcaloids
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
IN2012DN04858A (fr) * 2009-12-23 2015-09-25 Map Pharmaceuticals Inc
KR20140042868A (ko) * 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체
SG10201509139QA (en) 2011-12-19 2015-12-30 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
CA2859175A1 (fr) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Nouveaux composes neuromodulateurs
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
BR112022025306A2 (pt) 2020-06-12 2023-02-28 Beckley Psytech Ltd Composição compreendendo um sal benzoato de 5-metóxin, n-dimetiltriptamina
EP4155306A1 (fr) 2021-01-15 2023-03-29 Beckley Psytech Limited Analogue neuroactif d'ergoline
US12264131B2 (en) 2022-08-19 2025-04-01 Beckley Psytech Limited Pharmaceutically acceptable salts and compositions thereof
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof
US12246005B2 (en) 2023-06-13 2025-03-11 Beckley Psytech Limited 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508628A (de) * 1968-06-25 1971-06-15 Sandoz Ag Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
SE397093B (sv) * 1973-07-09 1977-10-17 Sandoz Ag Forfarande for framstellning av oktahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazinderivat
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
US4124712A (en) * 1976-09-06 1978-11-07 Sandoz Ltd. Ergot peptide alkaloid derivatives

Also Published As

Publication number Publication date
DK145701C (da) 1983-07-18
DK165778A (da) 1978-10-20
IE780759L (en) 1978-10-19
SE7804362L (sv) 1978-10-20
GB1584464A (en) 1981-02-11
FR2387989A1 (fr) 1978-11-17
CA1113410A (fr) 1981-12-01
SU735154A3 (ru) 1980-05-15
ATA260378A (de) 1982-06-15
CH637658A5 (it) 1983-08-15
DE2816773A1 (de) 1978-10-26
IE46797B1 (en) 1983-09-21
DK145701B (da) 1983-01-31
NL7804174A (nl) 1978-10-23
CS212760B2 (en) 1982-03-26
AT369783B (de) 1983-01-25
HU175173B (hu) 1980-05-28
JPS53132599A (en) 1978-11-18
US4230854A (en) 1980-10-28
FR2387989B1 (fr) 1980-07-04

Similar Documents

Publication Publication Date Title
LU90153I2 (fr) Modiodal 100 mg
NZ187453A (en) Benzsubstituted-1-substitutedpiperid-1'-ylphthalazines
JPS53115326A (en) Compass
FI773961A7 (fi) Alkoholiskt desinfektionsmedel med spordoedande verkan
JPS5442185A (en) Lighttweight accelerometer
BE865921A (fr) Analogues des alcaloides de l'ergot
ZA781527B (en) Derivatives of morphine
FI781635A7 (fi) Jordvattningsapparat med en roerlig vattningsanordning
FI783568A7 (fi) Metod foer framstaellning av laogkalorimargarin med proteinkoncentrat fraon skummjoelk
FI782122A7 (fi) Med drivarm foersedd vattensprinkler
GB2004652B (en) Accelerometer
FI782807A7 (fi) Vaermningsanlaeggning foersedd med vaermepump
JPS5491284A (en) Accelerometer
JPS5446809A (en) Purifying of heparine
AU3281078A (en) Ergot derivatives
MTP837B (en) Derivatives 2 finino-imidazolidire
JPS53103430A (en) Phenylamidine derivatives
SE7800269L (sv) Halvsyntetiska 4"-amino-oleandomycinderivat
FI54737B (fi) Med friktionsplanethjul foersedd vaexel
GB2007952B (en) Nursery techniques
PH13996A (en) 9-hydroxyethoxymethyl guanine derivatives
SE7800270L (sv) Halvsyntetiska 4"-erytromycin-a-derivat
GB1485738A (en) Ergot alkaloids
JPS5448290A (en) Accelerometer
JPS5415772A (en) Compass

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOCIETA FARMACEUTICI ITALIA S.P.A.

Effective date: 19870430